Gaudium IVF IPO Allotment LIVE: Check GMP, allotment status on BSE, NSE and Bigshare Services

Here’s how to check Gaudium IVF IPO allotment status on BSE

Step 1] Visit BSE website on this link - https://www.bseindia.com/investors/appli_check.aspx

Step 2] Select ‘Equity’ in the Issue Type

Step 3] Choose ‘Gaudium IVF & Women Health Limited’ in the Issue Name dropdown menu

Step 4] Enter either Application No. or PAN

Step 5] Verify by ticking on ‘I am not robot’ and click on ‘Search’

Your Gaudium IVF & Women Health IPO allotment status will be displayed on the screen.

Here are steps to check Gaudium IVF IPO allotment status on NSE

Step 1] Visit NSE allotment status page on its website here - https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

Step 2] Select ‘Equity and SME IPO bids’

Step 3] Choose ‘Gaudium IVF & Women Health Limited’ from the Issue Name dropdown menu

Step 4] Enter your PAN and Application Number

Step 5] Click on Submit.

Your Gaudium IVF IPO allotment status will be displayed on the screen.

Here are steps to check Gaudium IVF IPO allotment status on Bigshare Services

Step 1] Visit the web portal of Bigshare Services here - https://ipo.bigshareonline.com/IPO_Status.html

Step 2] Select ‘Gaudium IVF & Women Health Limited’ in the Select Company dropbox

Step 3] Choose among - Application Number/CAF No, Beneficiary ID, or PAN

Step 4] Enter the details as per the option selected

Step 5] Fill the captcha and hit on ‘Search’

Your Gaudium IVF & Women Health IPO allotment status will be displayed on the screen

Arihant Capital Markets said that Gaudium IVF appears well-positioned to benefit from the structurally growing fertility market in India, supported by its proprietary GAAT module, consistent clinical success rates of 58%, and stable treatment volumes.

The brokerage added that the company’s focus on personalized, genome-based solutions enhances clinical differentiation and premium positioning, while diversified revenue streams across IVF, hospital services, and pharmacy operations provide operational resilience.

Ventura Securities said the company’s asset-efficient hub-and-spoke model supports scalable growth, with operating margins above 40% and strong cost control. It added that comprehensive fertility offerings, favourable industry tailwinds, a medical tourism focus, and experienced leadership are driving sustained patient growth and revenue visibility.

However, the brokerage also cautioned that the company is exposed to regulatory and workforce retention risks in a specialist healthcare segment, where high attrition among key professionals could affect service quality.

It also highlighted significant contingent liabilities and intense competition from larger healthcare players, which may pressure margins and growth prospects.

BP Equities said the company's strategy centres on expanding its geographic footprint through a calibrated mix of hub strengthening and spoke additions, driving operating leverage through standardized SOPs, optimizing centre-level utilization, and enhancing brand visibility in high-growth urban and semi-urban markets.

The brokerage further noted that industry dynamics remain favourable, underpinned by rising infertility incidence, lifestyle-related reproductive challenges, delayed parenthood trends, improving awareness and social acceptance of IVF procedures, and increasing penetration of organized fertility chains in India's fragmented ART landscape.

For the half-year ended September 30, 2025 (H1 FY26), Gaudium IVF reported total income of ₹49.5 crore, with EBITDA at ₹18.9 crore and profit after tax (PAT) at ₹12.5 crore.

For FY2025, revenue from operations stood at ₹70.7 crore, while EBITDA was ₹28.9 crore and PAT came in at ₹19.1 crore, compared with revenue of ₹47.9 crore and PAT of ₹10.3 crore in FY2024, reflecting continued year-on-year growth.

The company proposes to utilize the proceeds from the IPO to support its expansion strategy, including setting up new IVF centers, investing in its wholly owned subsidiary EKK Global Pvt Ltd, and launching FMCG products. A portion of the funds will also be allocated toward working capital requirements and general corporate purposes.

Gaudium IVF IPO GMP (grey market premium) today is ₹4. Considering the IPO price of ₹79 and the current grey market premium, the estimated listing price of Gaudium IVF shares is indicated at ₹83 apiece, which is 5% higher than the issue price.

During the three-day bidding period between February 20 and 24, the mainboard IPO managed to attract bids worth ₹840 crore — 7.27 times higher than its offer size of ₹160 crore — with non-institutional investors placing bids worth ₹347 crore.

Although the IPO was fully subscribed on the first day, it gathered further momentum on the second day, with the subscription rate reaching 3.03 times. On the final day, investors showed the same enthusiasm, with the issue ultimately being oversubscribed 7.27 times.

Retail investors showed strong interest in the Gaudium IVF IPO, cumulatively bidding for 5.55 crore shares — 7.60 times higher than the 73 lakh shares allotted to them — resulting in total bids worth ₹439 crore.

Sarthi Capital Advisors Pvt. Ltd. is the book running lead manager and Bigshare Services Pvt. Ltd. is the Gaudium IVF IPO registrar.

Gaudium IVF IPO has been subscribed 7.27 times in total, BSE data showed. The public issue was booked 7.60 times in the Retail Individual Investors category, and 14.05 times in the Non Institutional Investors (NII) segment. The Qualified Institutional Buyers (QIBs) category received 1.62 times subscription.

Gaudium IVF IPO Allotment LIVE: Gaudium IVF & Women Health IPO price band was set at ₹75 to ₹79 per share. At the upper-end of the price band, the company raised ₹165 crore from the public issue, which was a combination of fresh issue of 1.14 crore equity shares worth ₹90 crore, and an offer-for-sale (OFS) of 94.93 lakh shares amounting to ₹75 crore.

Here are steps to check Gaudium IVF IPO allotment status on Bigshare Services

Step 1] Visit the web portal of Bigshare Services here - https://ipo.bigshareonline.com/IPO_Status.html

Step 2] Select ‘Gaudium IVF & Women Health Limited’ in the Select Company dropbox

Step 3] Choose among - Application Number/CAF No, Beneficiary ID, or PAN

Step 4] Enter the details as per the option selected

Step 5] Fill the captcha and hit on ‘Search’

Your Gaudium IVF & Women Health IPO allotment status will be displayed on the screen.

Here are steps to check Gaudium IVF IPO allotment status on NSE

Step 1] Visit NSE allotment status page on its website here - https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

Step 2] Select ‘Equity and SME IPO bids’

Step 3] Choose ‘Gaudium IVF & Women Health Limited’ from the Issue Name dropdown menu

Step 4] Enter your PAN and Application Number

Step 5] Click on Submit.

Your Gaudium IVF IPO allotment status will be displayed on the screen.

Here’s how to check Gaudium IVF IPO allotment status on BSE

Step 1] Visit BSE website on this link - https://www.bseindia.com/investors/appli_check.aspx

Step 2] Select ‘Equity’ in the Issue Type

Step 3] Choose ‘Gaudium IVF & Women Health Limited’ in the Issue Name dropdown menu

Step 4] Enter either Application No. or PAN

Step 5] Verify by ticking on ‘I am not robot’ and click on ‘Search’

Your Gaudium IVF & Women Health IPO allotment status will be displayed on the screen.

Gaudium IVF IPO Allotment LIVE: Investors can check Gaudium IVF IPO allotment status online through the websites of BSE and NSE, along with the official portal of the IPO registrar. Bigshare Services is the Gaudium IVF & Women Health IPO registrar.

Gaudium IVF IPO was open for public subscription from February 20 to February 24. Gaudium IVF IPO allotment date is likely today, February 25. Once the basis of share allotment is fixed, the company will then credit the equity shares into the demat accounts of eligible allotment holders and initiate refunds to unsuccessful bidders on February 26. Gaudium IVF IPO listing date is February 27, and the equity shares of Gaudium IVF & Women Health Ltd will be listed on both the stock exchanges, BSE and NSE.

Gaudium IVF & Women Health IPO allotment date is likely today, 25 February 2026. The initial public offering (IPO) of the IVF treatments major received strong demand during the subscription period.